HIV-1 TAT Clade-B Recombinant, HIV-1 TAT Clade-B, 10ug

Amino Acid Sequence
MEPVDPRLEP WKHPGSQPKT ACTNCYCKKC CFHCQVCFIT KALGISYGRK KRRQRRRPPQ GSQTHQVSLS KQPTSQSRGD PTGPKE.

Applications
Recognized by anti-Tat (HIV-1) polyclonal antibody.
Reacts with anti-Tat antibodies from human, monkey, rabbit and mouse serum.

Description
HIV-1 TAT Recombinant- produced in E.coli is a single, non-glycosylated, polypeptide chain containing 86 amino acids encoded by two exons and having chain having a molecular mass of 14kDa.

Physical Appearance

Sterile Filtered and lyophilized, though might appear as a solution as a result of the glycerol content.

Purity
Greater than 90.0% as determined by HPLC analysis and SDS-PAGE.

Solubility
It is recommended to reconstitute the lyophilized HIV-1 TAT in sterile 18M¦¸-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.

Source
Escherichia Coli.

Specificity
Immunoreactive with all sera of HIV-1 infected individuals.

Stability
Lyophilized HIV-1 TAT although stable at room temperature for 1 week, should be stored desiccated below -18¡ãC. Upon reconstitution HIV-1 TAT should be stored at 4¡ãC between 2-7 days and for future use below -18¡ãC.
For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.